{"id":97,"date":"2013-04-04T15:36:52","date_gmt":"2013-04-04T06:36:52","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=97"},"modified":"2013-04-04T16:36:31","modified_gmt":"2013-04-04T07:36:31","slug":"2011%e5%b9%b4%e3%80%80%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=97","title":{"rendered":"2011\u5e74\u3000\u5b66\u4f1a\u767a\u8868"},"content":{"rendered":"
    \n
  1. Arai S, Shibata Y, Suzuki K, Miyoshi Y, Kubota Y, Tsukamoto T, Ichikawa T, Namiki M, Sugimura Y, Okuyama A and Kanetake H.\uff1aPrediction of hormone-refractory prostate cancer on the basis of the pretreatment androgen content in prostate needle biopsy specimen.. \u7b2c26\u56de\u6b27\u5dde\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a, Mar. 20, 2011, Vienna, Austria.<\/li>\n
  2. Shibata Y, Arai S, Koike H, En bloc enucleation technique with lateral median approach for safe and quicker operation when performing holmium laser enucleation of the prostate.. \u7b2c26\u56de\u6b27\u5dde\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a, Mar.19, 2011, Vienna, Austria.<\/li>\n
  3. Shibata Y, Arai S, Koike H, Matsui H, Ito K, Honma S and Suzuki K.\u000b\uff1aExpression of genes encoding enzymes involved in androgen synthesis in human adipose tissue.. \u7b2c26\u56de\u6b27\u5dde\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a, Mar. 21, 2011, San Vienna, Austria.<\/li>\n
  4. Miyakubo M, Ito K, Yamamoto T and Suzuki K.\uff1aControversy. Diagnostic significance of [-2]proPSA, total and transition zone prostate volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0ng\/ml range.. \u7b2c26\u56de\u6b27\u5dde\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u5e74\u6b21\u7dcf\u4f1a, Mar. 19, 2011, Vienna, Austria.<\/li>\n
  5. Arai S, Shibata Y, Koike H, Matsui H, Ito K, Honma S and Suzuki K.\uff1aExpression of genes encoding enzymes involved in androgen synthesis in human adipose tissue -possibility of adipose tissue as the third organ producing active androgen in prostate cancer patients-. AUA 106th annual Meeting, May.15, 2011, Washington DC, USA.<\/li>\n
  6. Koike H, Sekine Y, Nitta T, Furuya Y,\u3000Morikawa Y, Matsui H, Shibata Y and Suzuki K.\uff1aHigh-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells.. AUA 106th annual Meeting, May. 15, 2011, Washington DC, USA.<\/li>\n
  7. Shibata Y, Arai S, Suzuki K, Honma S, Miyoshi Y, Kubota Y, Tsukamoto T, Ichikawa T, Namiki M, Sugimura Y, Okuyama A and Kanetake H.\uff1aPrediction of future castration resistant prostate cancer by pre-treatment prostate tissue androgen content.. AUA 106th annual Meeting, May 18, 2011, Washington DC, USA.<\/li>\n
  8. Sekine Y, Furuya Y, Koike H, Mastui H, Suzuki K and Remaley AT.\uff1aHigh fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.. AUA 106th annual Meeting, May. 16, 2011, Washington DC, USA.<\/li>\n
  9. Kobayashi M, Ito K, Miyakubo M and Suzuki K.\uff1aPredictive impact of free PSA\/total PSA (%fPSA) on the development of prostate cancer in men with baseline PSA lower than 2.0ng\/mL: baseline PSA-adjusted case control study.. \u7b2c31\u56de\u56fd\u969b\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a, Oct. 18, 2011, Berlin, Germany.<\/li>\n
  10. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5bcc\u7530\u3000\u5149\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u677f\u6a4b\u53cb\u91cc\u3001\u6e05\u6c34\u3000\u78a7\u3001\u77f3\u7530\u7d18\u7f8e\u3001\u5e02\u5ddd\u9ebb\u8863\u5b50\u3001\u6afb\u4e95\u667a\u5b50\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u5f8c\u85e4\u548c\u5f18\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u3067\u306e\u767a\u898b\u524d\u7acb\u817a\u304c\u3093\u75c7\u4f8b\u306b\u304a\u3051\u308bPSA\u751f\u9577\u66f2\u7dda\u306e\u691c\u8a0e.\u5e73\u621023\u5e74\u5ea6\u79cb\u5b63\u7fa4\u99ac\u770c\u533b\u5b66\u4f1a, 2011\u5e7412\u67083\u65e5, \u524d\u6a4b.<\/li>\n
  11. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u677f\u6a4b\u53cb\u91cc\u3001\u6e05\u6c34\u3000\u78a7\u3001\u77f3\u7530\u7d18\u7f8e\u3001\u5e02\u5ddd\u9ebb\u8863\u5b50\u3001\u6afb\u4e95\u667a\u5b50\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u5f8c\u85e4\u548c\u5f18\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306b\u304a\u3051\u308bPSA\u5e74\u9f62\u968e\u5c64\u5225\u57fa\u6e96\u5024\u306e\u691c\u8a0e. \u5e73\u621023\u5e74\u5ea6\u79cb\u5b63\u7fa4\u99ac\u770c\u533b\u5b66\u4f1a, 2011\u5e7412\u67083\u65e5, \u524d\u6a4b\u5e02.<\/li>\n
  12. \u95a2\u6839\u82b3\u5cb3\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u9234\u6728\u548c\u6d69\u3001Alan T. Remaley\uff1a\u9ad8\u8102\u80aa\u98df\u6295\u4e0e\u5f8c\u306e\u30de\u30a6\u30b9\u524d\u7acb\u817a\u306b\u304a\u3051\u308b\u7db2\u7f85\u7684\u907a\u4f1d\u5b50\u767a\u73fe\u89e3\u6790. \u7b2c27\u56de\u524d\u7acb\u817a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2011\u5e7412\u670810\u65e5, \u6771\u4eac.<\/li>\n
  13. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u9234\u6728\u548c\u6d69\u3001\u52a0\u85e4\u5f18\u4e4b\u3001\u4e2d\u91ce\u9686\u53f2\u3001\u77f3\u5ddd\u3000\u4ec1\u3001\u79cb\u5143\u54f2\u592b\uff1a\u5c40\u6240\u9032\u884c\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u5185\u5206\u6ccc\u30fb\u5916\u7167\u5c04\u30fb\u9ad8\u7dda\u91cf\u7387\u7d44\u7e54\u5185\u7167\u5c04\u4f75\u7528\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c27\u56de\u524d\u7acb\u817a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2011\u5e7412\u670811\u65e5, \u6771\u4eac.<\/li>\n
  14. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5468\u6771\u5b5d\u6cbb\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u751f\u691c\u3092\u8981\u3059\u308b\u60a3\u8005\u306e\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u306e\u65e5\u5185\u5909\u52d5\u3068\u8af8\u56e0\u5b50\u306e\u95a2\u4fc2. \u7b2c\uff12\u56de\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u7814\u7a76\u4f1a, 2011\u5e7411\u670825\u65e5, \u798f\u5ca1.<\/li>\n
  15. \u65b0\u4e95\u8aa0\u4e8c\u3001\u67f4\u7530\u5eb7\u535a\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u8102\u80aa\u7d44\u7e54\u5185\u306b\u304a\u3051\u308b\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u5408\u6210\u9175\u7d20\u306e\u907a\u4f1d\u5b50\u767a\u73fe\u89e3\u6790\u304a\u3088\u3073\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u5b9a\u91cf. \u65e5\u672c\u30a2\u30f3\u30c9\u30ed\u30ed\u30b8\u30fc\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a, 2011\u5e747\u670823\u65e5, \u6771\u4eac.<\/li>\n
  16. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u9234\u6728\u548c\u6d69\u3001\u4e09\u597d\u5eb7\u79c0\u3001\u7aaa\u7530\u5409\u4fe1\u3001\u585a\u672c\u6cf0\u53f8\u3001\u5e02\u5ddd\u667a\u5f66\u3001\u4e26\u6728\u5e79\u592b\u3001\u6749\u6751\u82b3\u6a39\u3001\u5965\u5c71\u660e\u5f66\u3001\u91d1\u6b66\u3000\u6d0b\uff1a\u524d\u7acb\u817a\u764c\u30db\u30eb\u30e2\u30f3\u6cbb\u7642\u306b\u304a\u3051\u308b\u6cbb\u7642\u524d\u7d44\u7e54\u5185\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u5b9a\u91cf\u306e\u610f\u7fa9. \u65e5\u672c\u30a2\u30f3\u30c9\u30ed\u30ed\u30b8\u30fc\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a, 2011\u5e747\u670822\u65e5, \u6771\u4eac.<\/li>\n
  17. \u67f4\u7530\u5eb7\u535a\uff1a\uff62\u524d\u7acb\u817a\uff1a\u767a\u764c\u30fb\u5897\u6b96\uff1a\u30db\u30eb\u30e2\u30f3\u3068\u306e\u63a5\u70b9\uff63
    \n\u524d\u7acb\u817a\u764c\u3068\u7d44\u7e54\u5185\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3. \u65e5\u672c\u30a2\u30f3\u30c9\u30ed\u30ed\u30b8\u30fc\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02, 2011\u5e747\u670823\u65e5, \u6771\u4eac.<\/li>\n
  18. \u95a2\u6839\u82b3\u5cb3\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u9234\u6728\u548c\u6d69\u3001Alan T. Remaley\uff1aHDL\u306b\u3088\u308b\u3001S1P\u3092\u4ecb\u3057\u305f\u524d\u7acb\u817a\u764c\u7d30\u80de\u904a\u8d70\u53ca\u3073\u6d78\u6f64\u52b9\u679c\u306e\u691c\u8a0e. \u65e5\u672c\u30a2\u30f3\u30c9\u30ed\u30ed\u30b8\u30fc\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a, 2011\u5e747\u670823\u65e5, \u76db\u5ca1.<\/li>\n
  19. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1aPSA\u57fa\u790e\u50242.0ng\/ml\u4ee5\u4e0b\u306e\u75c7\u4f8b\u306b\u304a\u3051\u308bfree PSA\/total PSA\u306e\u524d\u7acb\u817a\u304c\u3093\u7f79\u60a3\u4e88\u6e2c\u56e0\u5b50\u3068\u3057\u3066\u306e\u6709\u7528\u6027. \u7b2c19\u56de\u65e5\u672c\u304c\u3093\u691c\u8a3a\u30fb\u8a3a\u65ad\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e748\u67086\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  20. \u4f0a\u85e4\u4e00\u4eba\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u5c71\u672c\u3000\u5de7\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u7530\u4e2d\u5553\u5e79\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u30e1\u30f3\u30d0\u30fc\uff1a2009\u5e74\u5ea6\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u75be\u60a3\u7d99\u7d9a\u7814\u7a76\u30fb\u5bfe\u7167\u7814\u7a76\u306e\u691c\u8a3a\u7d50\u679c. \u7b2c49\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a,2011\u5e7410\u670828\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  21. \u4f0a\u85e4\u4e00\u4eba\uff1a\u300c\u524d\u7acb\u817a\u764c\u306e1\u6b21\u4e88\u9632\u30fb\u5316\u5b66\u4e88\u9632\u30fb\u691c\u8a3a\u300d\uff1a\u6b7b\u4ea1\u7387\u4f4e\u4e0b\u3068\u904e\u5270\u8a3a\u65ad\u306e\u72ed\u9593\u3067\uff1aPSA\u57fa\u6e96\u5024\u30fb\u751f\u691c\u9069\u5fdc\u30fb\u751f\u691c\u6cd5\u306e\u65b9\u5411\u6027. \u7b2c20\u56de\u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02,2011\u5e747\u67088\u65e5,\u524d\u6a4b.<\/li>\n
  22. \u7530\u6751\u82b3\u7f8e\u3001\u897f\u4e95\u660c\u5f18\u3001\u5927\u585a\u4fdd\u5b8f\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u91ce\u6751\u660c\u53f2\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u3068\u96c6\u56e3\u691c\u8a3a\u3067\u767a\u898b\u3055\u308c\u305f\u524d\u7acb\u817a\u764c\u75c7\u4f8b\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c20\u56de\u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a, 2011\u5e747\u67088\u65e5, \u524d\u6a4b.<\/li>\n
  23. \u677e\u4e95\u3000\u535a\u3001\u798f\u9593\u88d5\u4e8c\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5927\u7af9\u4f38\u660e\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u764c\u306e\u907a\u4f1d\u7684\u7d20\u56e0\uff1a\u524d\u7acb\u817a\u764c\u8cac\u4efb\u907a\u4f1d\u5b50\u306e\u540c\u5b9a. \u7b2c20\u56de\u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01, 2011\u5e747\u67088\u65e5, \u524d\u6a4b.<\/li>\n
  24. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c0f\u6797\u5e79\u7537\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u53e4\u4f5c\u3000\u671b\u3001\u677e\u672c\u548c\u4e45\u3001\u5c71\u672c\u3000\u5de7\u3001\u767b\u4e38\u884c\u96c4\u3001\u9234\u6728\u548c\u6d69\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC)\uff1a\u7fa4\u99ac\u30bb\u30af\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b2009\u5e74\u5ea6\u307e\u3067\u306e\u7814\u7a76\u7d50\u679c.\u7b2c20\u56de\u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a, 2011\u5e747\u67088\u65e5, \u524d\u6a4b.<\/li>\n
  25. \u67f4\u7530\u5eb7\u535a\uff08\u6f14\u8005\u4ea4\u4ee3\uff09\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u8102\u80aa\u7d44\u7e54\u5185\u306b\u304a\u3051\u308b\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u5408\u6210\u9175\u7d20\u306e\u907a\u4f1d\u5b50\u767a\u73fe\u89e3\u6790\u304a\u3088\u3073\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u5b9a\u91cf. \u7b2c19\u56de\u65e5\u672c\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u5b66\u4f1a, 2011\u5e7411\u670826\u65e5, \u76db\u5ca1.<\/li>\n
  26. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u6238\u585a\u771f\u5f13\u3001\u77f3\u4e95\u79c0\u548c\u3001\u66f2\u3000\u53cb\u5f18\u3001\u72e9\u91ce\u3000\u81e8\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u4eba\u9593\u30c9\u30c3\u30af\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306b\u304a\u3051\u308bPSA\u5e74\u9f62\u968e\u5c64\u5225\u57fa\u6e96\u5024\u306e\u691c\u8a0e. \u7b2c52\u56de\u65e5\u672c\u4eba\u9593\u30c9\u30c3\u30af\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a, 2011\u5e748\u670826\u65e5, \u5927\u962a.<\/li>\n
  27. \u66f2\u3000\u53cb\u5f18\u3001\u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u9234\u6728\u548c\u6d69\uff1a\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u304c\u8180\u80f1\u8840\u6d41\u3068\u6a5f\u80fd\u306b\u53ca\u307c\u3059\u5f71\u97ff\uff5eSHR\u30e9\u30c3\u30c8\u3092\u4f7f\u7528\u3057\u305f\u8180\u80f1\u3068\u8840\u7ba1\u306e\u7d44\u7e54\u5b66\u7684\u5909\u5316\u3082\u542b\u3081\u305f\u691c\u8a0e\uff5e. \u7b2c18\u56de\u65e5\u672c\u6392\u5c3f\u6a5f\u80fd\u5b66\u4f1a, 2011\u5e749\u670816\u65e5, \u798f\u4e95.<\/li>\n
  28. \u4f0a\u85e4\u4e00\u4eba\uff1aproPSA\uff1a\u65b0\u898f\u816b\u760d\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u81e8\u5e8a\u5fdc\u7528\u3078\u306e\u671f\u5f85. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6559\u80b2\u30bb\u30df\u30ca\u30fc, 2011\u5e744\u670822\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  29. \u5927\u7af9\u4f38\u660e\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u7530\u6751\u82b3\u7f8e\u3001\u4e2d\u6751\u654f\u4e4b\u3001\u9234\u6728\u5b5d\u61b2\u3001\u95a2\u539f\u54f2\u592b\u3001\u771f\u4e0b\u3000\u900f\u3001\u733f\u6728\u548c\u4e45\u3001\u53e4\u4f5c\u3000\u671b\u3001\u9234\u6728\u548c\u6d69\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u9234\u6728\u6176\u4e8c\u3001\u6df1\u5800\u80fd\u7acb\uff1a\u308f\u304c\u56fd\u306b\u304a\u3051\u308b\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c\u306b\u3064\u3044\u3066\u2015\u7b2c14\u5831\u2015. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670822\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  30. \u95a2\u6839\u82b3\u5cb3\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u9234\u6728\u548c\u6d69\u3001Alan T. Remaley\uff1aABCA1\u3092\u4ecb\u3057\u305fHDL\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u5897\u6b96\u6a5f\u69cb\u306e\u89e3\u660e. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670822\u65e5,\u540d\u53e4\u5c4b.<\/li>\n
  31. \u66f2\u3000\u53cb\u5f18\u3001\u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u67cf\u6728\u6587\u8535\u3001\u9234\u6728\u548c\u6d69\uff1a\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u304c\u8180\u80f1\u8840\u6d41\u3068\u6a5f\u80fd\u306b\u53ca\u307c\u3059\u5f71\u97ff\uff5e\u8180\u80f1\u3068\u8840\u7ba1\u306e\u7d44\u7e54\u5b66\u7684\u691c\u8a0e\u3082\u542b\u3081\u3066\uff5e. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 22011\u5e744\u670823\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  32. \u67f4\u7530\u5eb7\u535a\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u764c\u3068\u8102\u80aa\u7d44\u7e54\uff08\u7b2c\u4e00\u5831\uff09\u2212\u30d2\u30c8\u8102\u80aa\u7d44\u7e54\u5185\u6027\u30b9\u30c6\u30ed\u30a4\u30c9\u30db\u30eb\u30e2\u30f3\u4ee3\u8b1d\u306e\u691c\u8a0e\u2212. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670824\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  33. \u67f4\u7530\u5eb7\u535a\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u91ce\u6751\u660c\u53f2\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u7d4c\u5c3f\u9053\u7684\u30db\u30eb\u30df\u30a6\u30e0\u30ec\u30fc\u30b6\u30fc\u524d\u7acb\u817a\u6838\u51fa\u8853(HoLEP)\u7fd2\u5f97\u306b\u304a\u3051\u308b\u8853\u4e2d\u7d4c\u76f4\u8178\u7684\u524d\u7acb\u817a\u8d85\u97f3\u6ce2(TRUS)\u64cd\u4f5c\u7d4c\u9a13\u306e\u6709\u7528\u6027. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670821\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  34. \u5c0f\u6c60\u79c0\u548c\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u677e\u4e95\u3000 \u535a\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u518d\u71c3\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u30c9\u30bb\u30bf\u30ad\u30bb\u30eb\u7642\u6cd5\u306e\u691c\u8a0e. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670823\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  35. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c0f\u6797\u5e79\u7537\u3001\u7af9\u6fa4\u3000\u8c4a\u3001\u53e4\u4f5c\u3000\u671b\u3001\u677e\u672c\u548c\u4e45\u3001\u5c71\u672c\u3000\u5de7\u3001\u767b\u4e38\u884c\u96c4\u3001\u9234\u6728\u548c\u6d69\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC)\uff1a\u7fa4\u99ac\u30bb\u30af\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b2009\u5e74\u5ea6\u307e\u3067\u306e\u7814\u7a76\u7d50\u679c. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2011\u5e744\u670821\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  36. \u5bae\u5c3e\u6b66\u58eb\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c0f\u6797\u5e79\u7537\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u9234\u6728\u548c\u6d69\uff1a\u814e\u539f\u767a\u30e6\u30fc\u30a4\u30f3\u30b0\u8089\u816b\u306e\uff11\u4f8b. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670821\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  37. \u6817\u539f\u8070\u592a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u5bae\u5c3e\u6b66\u58eb\u3001\u91ce\u6751\u660c\u53f2\u3001\u67f4\u7530\u5eb7\u535a\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u7fa4\u99ac\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u6ccc\u5c3f\u5668\u79d1\u306b\u304a\u3051\u308b\u82e5\u5e74\u6027\u814e\u816b\u760d\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c99\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2011\u5e744\u670824\u65e5, \u540d\u53e4\u5c4b.<\/li>\n
  38. \u5bae\u4e45\u4fdd\u771f\u610f\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u5c71\u672c\u3000\u5de7\u3001\u9234\u6728\u548c\u6d69\uff1aPSA\u50242.0\uff5e10.0ng\/ml\u3067\u306e[-2]proPSA\u306e\u524d\u7acb\u817a\u304c\u3093\u8a3a\u65ad\u30fb\u751f\u7269\u5b66\u7684\u7279\u6027\u4e88\u6e2c\u306b\u304a\u3051\u308b\u6709\u7528\u6027\u306e\u691c\u8a3c. \u7b2c76\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a, 2011\u5e7410\u670821\u65e5, \u6a2a\u6d5c.<\/li>\n
  39. \u718a\u5742\u6587\u6210\u3001\u52a0\u702c\u5609\u660e\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5bcc\u7530\u3000\u5149\u3001\u72e9\u91ce\u3000\u81e8\u3001\u9ed2\u6fa4\u3000\u529f\u3001\u6238\u585a\u771f\u5f13\u3001\u5cf6\u7530\u548c\u5b50\u3001\u677e\u672c\u623f\u6c5f\u3001\u77f3\u4e95\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\uff1a\u8edf\u6027\u814e\u76c2\u5c3f\u7ba1\u30d3\u30c7\u30aa\u30b9\u30b3\u30fc\u30d7URF-V\u3092\u7528\u3044\u305f\u814e\u7d50\u77f3\u7834\u7815\u8853(f-TUL)\u306e\u7d4c\u9a13. \u4eba\u9593\u30c9\u30c3\u30af\u524d\u7acb\u817a\u304c\u3093\u75c7\u4f8b\u306b\u304a\u3051\u308bPSA\u751f\u9577\u66f2\u7dda\u306e\u691c\u8a0e,2011\u5e7410\u670821\u65e5, \u6a2a\u6d5c.<\/li>\n
  40. \u5ee3\u91ce\u6b63\u6cd5\u3001\u5c71\u672c\u3000\u5de7\u3001\u677e\u672c\u548c\u4e45\u3001\u6797\u3000\u96c5\u9053\u3001\u53e4\u4f5c\u3000\u671b\u3001\u9577\u8c37\u5ddd\u662d\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u5468\u6771\u5b5d\u6d69\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u9234\u6728\u548c\u6d69\u3001\u5e73\u6238\u7d14\u5b50\uff1a\u4e0d\u660e\u71b1\u3092\u5951\u6a5f\u306bPET-CT\u3067\u767a\u898b\u3055\u308c\u305f\u900f\u6790\u814e\u764c\u306e\u4e00\u4f8b. \u7b2c57\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2011\u5e742\u670812\u65e5, \u524d\u6a4b.<\/li>\n
  41. \u5bae\u5c3e\u6b66\u58eb\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u6817\u539f\u8070\u592a\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5468\u6771\u5b5d\u6d69\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u5c3f\u8def\u4e0a\u76ae\u764c\u3068\u9451\u5225\u56f0\u96e3\u3067\u3042\u3063\u305f\u5de8\u5927MFH\u306e\u4e00\u4f8b. \u7b2c57\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e742\u670812\u65e5, \u524d\u6a4b.<\/li>\n
  42. \u9234\u6728\u667a\u7f8e\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u85e4\u585a\u96c4\u53f8\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5468\u6771\u5b5d\u6d69\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u4e2d\u5ddd\u3000\u5fb9\uff1a\u53f3\u7cbe\u5de3\u3092\u539f\u767a\u5de3\u3068\u3059\u308b\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u4e00\u4f8b. \u7b2c58\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e746\u670811\u65e5, \u524d\u6a4b.<\/li>\n
  43. \u52a0\u85e4\u6625\u96c4\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u9234\u6728\u667a\u7f8e\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5468\u6771\u5b5d\u6d69\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u91ce\u6751\u660c\u53f2\u3001\u897f\u4e95\u660c\u5f18\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u7cbe\u5de3\u9798\u819c\u306b\u767a\u751f\u3057\u305f\u6f3f\u6db2\u6027\u5883\u754c\u60aa\u6027\u816b\u760d(serous borderline tumor; SBT)\u306e\u4e00\u4f8b. \u7b2c58\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e746\u670811\u65e5, \u524d\u6a4b.<\/li>\n
  44. \u4e2d\u5d8b\u3000\u4ec1\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5468\u6771\u5b5d\u6d69\u3001\u9234\u6728\u667a\u7f8e\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u91ce\u6751\u660c\u53f2\u3001\u52a0\u85e4\u6625\u96c4\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u5c71\u4f73\u6210\u3001\u72e9\u91ce\u3000\u81e8\u3001\u66f2\u3000\u53cb\u5f18\u3001\u5c0f\u5009\u6cbb\u4e4b\u3001\u9ed2\u6fa4\u3000\u529f\uff1a\u5c3f\u7ba1\u52d5\u8108\u763b\u306e\u4e00\u4f8b. \u7b2c58\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e746\u670811\u65e5, \u524d\u6a4b.<\/li>\n
  45. \u9234\u6728\u667a\u7f8e\u3001\u52a0\u85e4\u6625\u96c4\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5468\u6771\u5b5d\u6d69\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1aPaclitaxel, Cisplatin, 5-FU\u306b\u3088\u308b\u5316\u5b66\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f\u9670\u830e\u764c\u306e\u4e00\u4f8b. \u7b2c59\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e7411\u670812\u65e5, \u524d\u6a4b.<\/li>\n
  46. \u53e4\u8c37\u6d0b\u4ecb\u3001\u67f4\u7530\u5eb7\u535a\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u9234\u6728\u667a\u7f8e\u3001\u52a0\u85e4\u6625\u96c4\u3001\u4e2d\u5d8b\u3000\u4ec1\u3001\u85e4\u585a\u96c4\u53f8\u3001\u5468\u6771\u5b5d\u6d69\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u9ad8\u6838\u51fa\u52b9\u7387\u3092\u76ee\u6307\u3057\u305f\u30db\u30eb\u30df\u30a6\u30e0\u30ec\u30fc\u30b6\u30fc\u524d\u7acb\u817a\u6838\u51fa\u8853(HoLEP)\u306e\u5de5\u592b. \u7b2c59\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e7411\u670812\u65e5, \u524d\u6a4b.<\/li>\n
  47. \u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5468\u6771\u5b5d\u6d69\u3001\u52a0\u85e4\u6625\u96c4\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u5c3f\u8def\u4e0a\u76ae\u764c\u306b\u5bfe\u3059\u308bGC\u7642\u6cd5\u306b\u304a\u3051\u308b5-HT3\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u306e\u6bd4\u8f03. \u7b2c59\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a,2011\u5e7411\u670812\u65e5, \u524d\u6a4b.<\/li>\n
  48. \u95a2\u6839\u82b3\u5cb3\u3001\u5bae\u5c3e\u6b66\u58eb\u3001\u5468\u6771\u5b5d\u6d69\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u7530\u6751\u82b3\u7f8e\u3001\u897f\u4e95\u660c\u5f18\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u5f8c\u8179\u819c\u93e1\u624b\u8853\u3067\u5de6\u7cbe\u5de3\u9759\u8108\u30fb\u7cbe\u7ba1\u6458\u9664\u53ca\u3073\u5f8c\u8179\u819c\u30ea\u30f3\u30d1\u7bc0\u90ed\u6e05\u8853\u3092\u65bd\u884c\u3057\u305f\u65ad\u7aef\u967d\u6027\u5de6\u7cbe\u7d22\u539f\u767a\u60aa\u6027\u7dda\u7dad\u6027\u7d44\u7e54\u7403\u75c7\u306e\uff11\u4f8b. \u7b2c25\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u5185\u8996\u93e1\u5916\u79d1\u5b66\u4f1a,2011\u5e7411\u670830\u65e5, \u4eac\u90fd.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Arai S, Shibata Y, Suzuki K, Miyoshi Y, Kubota Y, Tsukamoto T, Ichikawa T, Namiki M, Sugimura Y, Okuyama A and […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-97","post","type-post","status-publish","format-standard","hentry","category-society"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/97","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=97"}],"version-history":[{"count":0,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/97\/revisions"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=97"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=97"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=97"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}